Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

BOSTON SCIENTIFIC CORPORATION

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Optimum Duration of Acoustic Pulse Thrombolysis Procedure in Acute Pulmonary Embolism

Phase 4

Completed

Conditions: Pulmonary Embolism and Thrombosis

Interventions: Device: Ekosonic® Endovascular Device ultrasonic infusion catheter
Biological: Recombinant tissue plasminogen activator

First Posted Date: 2015-03-24

Last Posted Date: 2021-07-19

Lead Sponsor: Boston Scientific Corporation

Target Recruit Count: 131

Registration Number: NCT02396758

Locations: 🇺🇸
Cedars Sinai, Beverly Hills, California, United States
🇺🇸
Tallahassee Memorial Hospital, Tallahassee, Florida, United States
🇺🇸
Florida Hospital Tampa, Tampa, Florida, United States

and more 18 locations

Renal Denervation Using the Vessix Renal Denervation System for the Treatment of Hypertension (REDUCE HTN:REINFORCE)

Not Applicable

Completed

Conditions: Hypertension

Interventions: Device: Renal Angiography
Device: Renal Denervation (Vessix)

First Posted Date: 2015-03-19

Last Posted Date: 2021-02-11

Lead Sponsor: Boston Scientific Corporation

Target Recruit Count: 51

Registration Number: NCT02392351

Locations: 🇺🇸
Cardiology, PC, Birmingham, Alabama, United States
🇺🇸
Cedars - Sinai Medical Center, Los Angeles, California, United States
🇺🇸
Mount Sinai Medical Center, Miami Beach, Florida, United States

and more 9 locations

A Study to Evaluate the Effect of Precision Spectra™ Programming Features and Lead Options on Patient Outcomes

Not Applicable

Terminated

Conditions: Chronic Pain

Interventions: Device: Conventional single source programming
Device: Precision Spectra SCS System advanced programming

First Posted Date: 2015-03-10

Last Posted Date: 2020-11-20

Lead Sponsor: Boston Scientific Corporation

Target Recruit Count: 17

Registration Number: NCT02384096

Locations: 🇺🇸
Physicians Research Group, LLC, Phoenix, Arizona, United States
🇺🇸
Albany Medical Center, Albany, New York, United States
🇺🇸
PCPMG Clinical Research Unit, LLC, Greenville, South Carolina, United States

and more 1 locations

REPRISE Next Generation Delivery System

Not Applicable

Completed

Conditions: Aortic Stenosis

Interventions: Device: Lotus Valve and LOTUS Edge Valve System

First Posted Date: 2014-12-31

Last Posted Date: 2018-05-24

Lead Sponsor: Boston Scientific Corporation

Target Recruit Count: 38

Registration Number: NCT02329496

Locations: 🇦🇺
Prince Charles Hospital, Chermside, Queensland, Australia
🇦🇺
Monash Heart, Clayton, Victoria, Australia

Effectiveness of the Precision Spinal Cord Stimulator System at Sub-Perception Amplitude

Not Applicable

Completed

Conditions: Chronic Pain

Interventions: Device: Precision or Precision Spectra Spinal Cord Stimulator System

First Posted Date: 2014-12-10

Last Posted Date: 2021-02-11

Lead Sponsor: Boston Scientific Corporation

Target Recruit Count: 229

Registration Number: NCT02314000

Locations: 🇺🇸
MORE Foundation, Phoenix, Arizona, United States
🇺🇸
Coastal Pain & Spinal Diagnostics, Carlsbad, California, United States
🇺🇸
Kaiser Foundation Hospital - Redwood City, Redwood City, California, United States

and more 23 locations

SpyGlass Direct Visualization System Clinical Registry in China

Completed

Conditions: Biliary Tract Diseases

Interventions: Device: SpyGlass

First Posted Date: 2014-11-10

Last Posted Date: 2018-07-31

Lead Sponsor: Boston Scientific Corporation

Target Recruit Count: 197

Registration Number: NCT02287194

Locations: 🇨🇳
Shanghai Changhai Hospital, Shanghai, Shanghai, China

SpyGlass AMEA Registry

Completed

Conditions: Biliary Stricture
Biliary Obstruction Due to Common Bile Duct Stone
Hemobilia
Periampullary Tumor

Interventions: Procedure: ERCP (Endoscopic Retrograde Cholangiopancreatography)
Device: SpyGlass DVS and SpyGlass Digital Simple (DS)

First Posted Date: 2014-11-02

Last Posted Date: 2019-07-10

Lead Sponsor: Boston Scientific Corporation

Target Recruit Count: 526

Registration Number: NCT02281019

Locations: 🇦🇺
Royal Brisbane and Women's Hospital, Herston, Queensland, Australia
🇦🇺
Royal Adelaide Hospital, Adelaide, Australia
🇦🇺
Royal Prince Alfred Hospital, Newtown, Australia

and more 17 locations

Short Term Pancreatic Stenting Registry

Completed

Conditions: Pancreatic Duct Stones
Pancreatic Duct Leakage
Pancreatic Duct Stricture
Post-ERCP Acute Pancreatitis

Interventions: Device: The Advanix™ Pancreatic Stent and NaviFlex RX Pancreatic Delivery System and Pushers

First Posted Date: 2014-10-13

Last Posted Date: 2017-03-21

Lead Sponsor: Boston Scientific Corporation

Target Recruit Count: 246

Registration Number: NCT02262845

Locations: 🇺🇸
Temple University School of Medicine, Philadelphia, Pennsylvania, United States
🇺🇸
Medical University of South Carolina, Charleston, South Carolina, United States
🇺🇸
Methodist Dallas Medical Center, Dallas, Texas, United States

and more 4 locations

Prospective, Multi-Center All-Comer Biliary Canadian WallFlex Registry

Completed

Conditions: Biliary Strictures

Interventions: Device: WallFlex™ Biliary RX Fully Covered Stent System RMV
Device: WallFlex™ Biliary RX Partially Covered Stent System
Device: WallFlex™ Biliary RX Uncovered Stent System

First Posted Date: 2014-10-10

Last Posted Date: 2020-01-06

Lead Sponsor: Boston Scientific Corporation

Target Recruit Count: 415

Registration Number: NCT02261623

Locations: 🇨🇦
Peter Lougheed Centre, Calgary, Alberta, Canada
🇨🇦
Royal Alexandra Hospital, Edmonton, Alberta, Canada
🇨🇦
University of Alberta Hospital, Edmonton, Alberta, Canada

and more 9 locations

PLATINUM Diversity

Completed

Conditions: Atherosclerosis
Coronary Artery Disease

Interventions: Device: Percutaneous coronary intervention (Promus PREMIER)

First Posted Date: 2014-09-16

Last Posted Date: 2019-05-15

Lead Sponsor: Boston Scientific Corporation

Target Recruit Count: 1501

Registration Number: NCT02240810

Locations: 🇺🇸
St Luke's Medical Center, Phoenix, Arizona, United States
🇺🇸
St Bernards Heart and Vascular, Jonesboro, Arkansas, United States
🇺🇸
Arkansas Cardiology/Baptist Health Medical Center, Little Rock, Arkansas, United States

and more 49 locations

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy